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 Abstract    
Objectives: The frequency of aneuploidies in human oocytes is extremely high. It is hypothesized that the cause 
may be due to abnormal chromatin (histone) acetylation/deacetylation. The aim of our study was to analyzed the 
acetylation/deacetylation pattern in spare human oocytes. 
Materials and Methods: Human spare oocytes (311), in other words oocytes that were not mature when col-
lected from follicles or control oocytes (bovine, mouse), were fixed with paraformaldehyde and then labeled with 
antibodies against acetylated histones. 
Results: Labeling against AcH4/K12 or hyperacetylated H4 showed high intensity of the fluorescence signal in all 
immature (germinal vesicle staged) and approximately 50% of the maturing (mature) oocytes. 
Conclusion: In conclusion, the labeling of human oocytes (chromosomes) showed very inconsistent patterns of 
acetylation/deacetylation, what may suggest they did not reach the metaphase II stage at the time of follicle aspi-
ration, and were epigenetically abnormal. It may also explain the high frequency of chromosomal abnormalities in 
human oocytes.
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 Streszczenie 
Cel: Częstość aneuploidii w ludzkich oocytach jest niezmiernie wysoka. Istnieją hipotezy, że jest to związane z 
nieprawidłową acetylacją/deacetylacją chromatyny (histonów). Celem badania była ocena wzoru acetylacji/deace-
tylacji w niewykorzystanych ludzkich oocytach.
Materiał i metoda: Ludzkie niewykorzystane oocyty (311), innymi słowy oocyty niedojrzałe w momencie pobrania 
z pęcherzyków lub oocyty kontrolne (krowie, mysie), zatopiono w paraformaldehydzie i oznakowano przeciwciałami 
przeciwko acetylowanym histonom.
Wyniki: Znakowanie przeciwko AcH4/K12 lub hiperacetylacja H4 wykazały wysoką częstość sygnału fluorescen-
cyjnego we wszystkich niedojrzałych (w stadium pęcherzyka germinalnego) i w około 50% dojrzałych oocytach.
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Introduction
The	frequency	of	aneuploidies	in	human	oocytes	is	very	high	
and	up	to	60%	of	them	have	been	reported	to	be	chromosomally	
abnormal	[1].	The	incidence	in	humans	seems	to	be	much	higher	
than	in	other	mammals:	mouse	–	approximately	5%,	cattle	–	10%,	
pig	–	10%	[2].	It	must	be,	however,	emphasized	that	these	estima-
tions	often	differ,	depending	on	the	technique	used.	The	reason	
why	 human	 oocytes	 are	 so	 often	 chromosomally	 abnormal	 re-
mains	undiscovered.	In	fact,	the	basis	for	aneuploidies	can	be	es-
tablished	long	before	they	can	be	detected	in	fully	grown	oocytes	
[3].	Hunt	 and	Hassold	 [3]	 defined	 three	 developmental	 phases	
of	oogenesis	when	the	quality	of	oocytes	can	be	influenced	–	i/	
oogenesis,	ii/	follicle	formation	and	iii/	oocyte	growth	and	matu-
ration.	The	 research	 in	 this	 field	 in	 humans	 is	mostly	 oriented	
towards	the	final	phase	of	the	oocyte	development:	its	maturation	
covering	the	period	when	the	oocyte	undergoes	germinal	vesicle	
breakdown	and	subsequently	reaches	the	metaphase	II	stage	[4].	
Highly	 dynamic	 morphological	 changes	 and	 specific	 histone	
modifications	 were	 reported	 to	 occur	 in	 mammalian	 oocytes	
within	that	 time	period.	An	immature	oocyte	contains	a	promi-
nent	 nucleus	 (germinal	 vesicle	 –	GV),	 in	which	 a	well-visible	
nucleolus	 can	 be	 seen	 in	 some	 species	 (rodents,	 humans,	 pig).	
A	germinal	vesicle	breakdown	(GVBD),	in	other	words	the	dis-
solution	of	GV	membrane,	disappearance	of	nucleoli	and	gradual	
condensation	 of	 chromatin,	 occurs	 following	 a	 gonadotropin	
surge	 or	 in	 in	 vitro	 cultures.	The	 condensed	 chromosomes	 are	
then	arranged	in	the	metaphase	I	stage	(MI)	with	a	well-formed	
spindle.	This	stage	is	followed	by	a	short	anaphase	to	telophase	
I	 (A-TI)	 transition,	during	which	 a	half	 of	 the	oocyte	 chromo-
some	complement	is	extruded	from	the	oocyte	in	the	form	of	the	
first	polar	body	(PBI).	The	chromosomes	are	again	arranged	on	
a	metaphase	plate	(metaphase	II,	MII).	
In	most	mammals,	the	oocyte	is	released	from	the	follicle	at	
that	stage	and	then	fertilized	by	the	sperm.	The	histone	modifica-
tions	studies	are	mostly	focused	on	acetylation	and	methylation,	
while	the	most	exhaustive	experiments	were	performed	in	mice.	
Methylation	of	chromatin	has	been	reported	to	be	rather	constant	
and	positive	labeling	was	detected	not	only	on	condensed	chro-
mosomes	(MI,	A-TI,	MII),	but	also	in	the	nuclei	[5,	6].	Quite	dif-
ferent	situation	was,	however,	observed	when	antibodies	against	
acetylated	histones	were	used.	In	general,	germinal	vesicles	were	
consistently	positively	labeled	but	as	soon	as	chromosomes	con-
densed	(MI,	MII),	no	labeling	was	detected.	The	only	exception	
is	the	anaphase	to	telophase	I	(A-TI)	transition	with	a	weak	signal	
on	chromosomes	 [7,	8,	9,	10].	 It	must	be	noted,	however,	 that	
a	different	pattern	of	labeling	was	detected	in	pigs,	where	chro-
matin	remained	acetylated	[11].	
Interestingly,	 the	oocyte	chromosome	acetylation	has	been	
shown	to	increase	with	age	of	the	female	and	also	some	IVF	(in	
vitro	fertilization)	techniques	may	be	the	influencing	factor	[12,	
13,	14].	A	clear	association	between	the	aberrant	acetylation	pat-
tern	and	the	unequal	segregation	of	chromosomes	has	been	dem-
onstrated	in	mice	[15,	16].	Whilst	in	oocytes	isolated	from	young	
females	no	positive	labeling	was	detected	on	condensed	chromo-
somes,	in	oocytes	from	old	females	about	half	of	the	metaphases	
showed	a	positive	signal.	The	increased	acetylation	of	chromo-
somes	was	also	detected	in	oocytes	aged	in	culture	(MII).	Thus,	
it	is	logical	to	assume	that	similar	situation	may	exist	in	humans,	
too.	As	mentioned	above,	human	oocytes	are	often	chromosom-
ally	abnormal	and	thus	one	can	expect	that	the	analysis	of	chro-
mosome	acetylation	pattern	will	correlate	with	aneuploidies.	To	
the	best	of	our	knowledge,	only	two	papers	on	the	acetylation	in	
human	oocytes	were	published	after	the	completion	of	our	study	
[17,	18].	We	analyzed	the	pattern	of	acetylation	in	spare	human	
oocytes,	i.e.	those	that	did	not	reach	the	metaphase	II	stage	at	the	
time	of	their	aspiration	from	the	follicles	or	eventually	remained	
unfertilized	after	IVF.	
Material and methods
Human	 oocytes,	 after	 standard	 stimulation,	were	 collected	
by	 aspiration	 from	 follicles	 and	 immediately	 morphologically	
evaluated.	Written	consent	was	obtained	from	all	couples	and	the	
study	was	approved	by	the	Ethical	Board	of	GENNET.	In	total,	
we	analyzed	311	oocytes	obtained	from	152	patients,	aged	from	
26	to	38	years,	treated	at	GENNET	for	a	wide	range	of	infertility	
problems	(endometriosis,	tubal	factors,	PCOS	-	polycystic	ovar-
ian	 syndrome,	 anovulation,	 genetic	 factors,	male	 factors,	 etc.).	
The	mature	oocytes,	i.e.	the	metaphase	II	staged,	were	used	either	
for	 ICSI	 or	were	mixed	with	 spermatozoa.	The	 remaining	 oo-
cytes	were	briefly	cultured	(2-3h)	in	Quinns	Advantage	Protein	
Plus	Cleavage	Medium	(SAGE	IVF,	Trumbull,	CT,	USA)	at	37oC	
and	5%	CO
2;
	during	that	period	some	oocytes	expelled	first	polar	
bodies.	Thereafter,	zonae	pellucidae	were	dissolved	by	pronase	
(0.5%)	in	PBS	(phosphate	buffered	saline)	and	then	the	oocytes	
were	fixed	with	4%	paraformaldehyde	(PFA)	in	PBS	for	30min.	
The	oocytes	were	 then	kept	 in	PBS	at	4°C	until	 immunolabel-
ing.	Before	 labeling	 the	 oocytes	were	 permeabilized	 by	Triton	
X-100	(0.2%	in	PBS)	for	10min	and	then	blocked	overnight	in	
PBS	 supplemented	with	1%	BSA	 (bovine	 serum	albumin)	 and	
0.1%	 TritonX-100	 at	 4°C.	 The	 oocytes	 were	 then	 incubated	
overnight	with	one	of	 the	 following	 antibodies:	 anti-acetylated	
H4/K12	 (1:800,	Upstate)	 and	 anti-hyperacetylated	H4	 (1:1000,	
Upstate).	These	antibodies	were	extensively	characterized	in	our	
laboratory	[5]	or	were	most	widely	used	in	studies	analyzing	the	
acetylation/deacetylation	processes	during	oocyte	maturation	in	
different	mammals	 (anti-acetylated	H4/K12).	Following	 the	 in-
cubation	with	one	of	the	above	mentioned	antibodies,	the	oocytes	
were	washed	several	times	in	PBS/BSA	and	then	incubated	for	2h	
Wnioski: Znakowanie ludzkich oocytów (chromosomów) wykazuje wysoce niejednoznaczny model acetylacji/de-
acetylacji, co może sugerować, że nie osiągają one metafazy II podziału w momencie aspiracji pęcherzyka i są 
epigenetycznie nieprawidłowe. Ten fakt może tłumaczyć wysoką częstość nieprawidłowości chromosomalnych w 
ludzkich oocytach.
 Słowa kluczowe: oocyt /dojrzewanie /chormosom /acetylacja /aneuploidia /
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with	the	secondary	antibody	(1:400,	donkey-anti	rabbit,	Jackson	
Immunoresearch).	The	oocytes	were	then	washed	several	times	
in	PBS/BSA,	mounted	on	slides	in	Vectashield	mounting	medium	
with	DAPI	(Vector	Laboratories)	and	examined	under	Olympus	
IX	 71	 fluorescence	 microscope.	 Each	 labeling	 was	 performed	
several	 times.	Unless	otherwise	stated,	all	 chemicals	were	pur-
chased	from	Sigma.
Control animal oocytes
In	order	to	exclude	some	technical	problems	in	labeling,	we	
used	 bovine	 and	mouse	 oocytes	 at	 different	 stages	 of	matura-
tion	as	controls.	Bovine	oocytes	were	aspirated	from	large	antral	
follicles	and	either	fixed	immediately	(GV	stage)	or	cultured	in	
M199	supplemented	with	FCS	(fetal	calf	serum,	10%),	gentami-
cin	(50µg/ml),	Na-pyruvate	(0.2	mM)	and	Pergonal	(0.1	IU/ml,	
Serono,	UK)	for	18-20h	at	38.5oC/5%	C0
2	
in	the	air	(maturing	–	
MI,	mature	–	MII)	and	then	fixed.	Mouse	oocytes	were	isolated	
from	 ovaries	 of	 PMSG	 (pregnant	mare	 serum	 gonadotropin,	 5	
I.U.)	stimulated	mice	(BDF1)	and	either	fixed	immediately	(GV)	
or	matured	in	MEM	supplemented	with	BSA	(4mg/ml),	gentami-
cin	(50	µg/ml)	and	Na-pyruvate	(0.2	mM)	at	37o/ 5%	C0
2	
in the 
air	for	up	to	12h	and	then	fixed.	The	oocytes	of	both	species	were	
treated	and	labeled	similarly	as	described	above	for	 the	human	
oocytes.	As	the	animal	oocytes	can	be	easily	distinguished	from	
the	human	oocytes,	they	were	often	incubated	in	the	same	well.
Results
The	results	are	summarized	in	Table	I.	It	must	be	noted	that	
we	analyzed	only	the	oocytes	with	no	signs	of	degeneration,	i.e.	
round-shaped	with	homogeneous	cytoplasm.	
First,	we	tested	the	antibody	that	was	specific	for	AcH4/K12.	
Controls,	 i.e.	 bovine	 (25)	 and	 mouse	 (42)	 GV	 staged	 oocytes	
were	always	positively	labeled,	whereas	in	human	oocytes	90%	
(95/105)	of	the	immature	oocytes	showed	positive	labeling	(Fig	
1	a,b).	No	labeling	at	all	was	detected	in	the	remaining	ones.	47%	
of	maturing	MI	stage	oocytes	were	positively	labeled	(27/58),	all	
telophase	I	(TI)	were	positive	(Figure	2	a,b),	and	49%	(22/45)	of	
the	metaphase	II	oocytes	showed	a	positive	signal.	Bovine	and	
mouse	maturing	and	mature	oocytes	showed	mostly	no	labeling	
(90%).
Anti-hyperacetylated	H4	was	used	as	 the	second	antibody.	
In	that	case,	almost	all	human	immature	GV	staged	oocytes	were	
positively	 labeled	 (95%;	 35/37).	About	 half	 of	 the	 metaphase	
I	 (48%;	40/83)	 and	 the	metaphase	 II	 (50%;	9/18)	was	positive	
when	this	antibody	was	used,	whilst	the	other	half	was	without	
labeling.	All	telophase	I	stage	oocytes	were	positively	labeled.	
The	 expected	pattern	of	 labeling	was	detected	 in	 controls,	
i.e.	in	bovine	and	murine	oocytes.	Here,	all	GV–staged	oocytes	
were	positively	labeled	(bovine	–	15,	murine	–	25),	in	maturing	
oocytes	no	labeling	was	detected	in	almost	all	oocytes	(45	–	bo-
vine,	 56	–	murine).	Surprisingly,	we	 found	 evident	 differences	
in	labeling	when	comparing	the	pattern	of	labeling	(AcH4/K12,	
anti-hyperacetylated	 H4)	 between	 oocytes	 obtained	 from	 the	
younger	and	 the	older	patients,	 (under	and	over	 the	age	of	30,	
respectively).	Similarly,	we	were	unable	to	find	any	relationship	
between	the	pattern	of	labeling	and	a	given	fertility	problem.	
In	conclusion,	when	compared	to	other	species	tested	so	far,	
our	results	demonstrate	that	the	analysis	of	acetylation/deacety-
lation	of	chromatin	in	human	oocytes	gave	us	rather	inconsistent	
results	.	At	present,	it	would	be	very	difficult	to	use	this	labeling	
to	 evaluate	 the	 quality	 of	 oocytes	 and	 to	 explain	 the	 high	 fre-
quency	of	aneuploidies	in	them.
Discussion
The	 ovary	 contains	 basically	 three	 categories	 of	 oocytes:	
growing,	intermediate	and	full-grown.	Only	full-grown	oocytes	
can	 undergo	 germinal	 vesicle	 breakdown	 and	 reach	 the	 meta-
phase	 II	 stage	 [4].	This,	 however,	 does	not	mean	 that	 they	 are	
chromosomally	 normal	 and	 developmentally	 fully	 competent.	
For	example,	 it	has	been	convincingly	demonstrated	 that	 those	
oocytes	where	the	nucleolus	is	surrounded	with	a	ring	of	chroma-
tin	are	the	best	ones.	
In	general,	GV	(immature)	oocytes	of	all	mammalian	species	
labeled	 so	 far	with	 antibodies	 against	 acetylated	histones	were	
positive	[19,	20,	21],	but	the	use	of	these	antibodies	(anti-AcH4/
K12,	anti-hyperacetylated	H4)	also	indicates	that	the	extrapola-
tion	of	 the	 results	obtained	 in	 laboratory	and	domestic	animals	
to	 humans,	 in	 order	 to	 explain	 the	 frequency	 of	 aneuploidies,	
may	be	risky.	Essentially,	our	results	are	in	agreement	with	the	
observations	of	van	der	Berg	et	al.	[18],	who	found	that	all	im-
mature	 oocytes	 (GV)	 labeled	 with	 anti-AcH4/K12	 antibody	
and	 approximately	50%	of	MI	 and	MII	oocytes	were	positive.	
Moreover,	 detailed	 analyses	 demonstrate	 a	 positive	 correlation	
between	 positive	 labeling	 and	 abnormal	 spindle	 morphology.	
This	may	consequently	lead	to	unequal	distribution	of	the	chro-
mosomal	material,	either	during	the	exit	from	the	metaphase	I	or	
the	metaphase	 II.	Their	 results,	however,	also	show	that	 it	will	
be	difficult	to	find	any	relationship	between	the	acetylation	pat-
tern	and	aberrant	chromosome	segregation.	AcH4K12	seems	to	
be	 the	most	convenient	of	all	antibodies	 they	 tested	 (AcH4K5,	
AcH4K8,	AcH4K12,	AcH4K16).	These	authors	also	found	cer-
tain	 differences	 in	 labeling	 (AcH4/K12)	 between	 the	 oocytes	
Table I. Chromosone Acetylation in Human Oocytes.
Antibody
Oocyte maturation stage – No of oocytes (±; positive/negative labeling) [%]
GV MI A-TI MII
AcH4K12 105 (95/10) [95/10] 58 (27/31) [47/53] 2 (2/0) [100/0] 45 (22/23) [49/51]
HyperAcH4 37 (35/2) [95/5] 83 (40/43) [48/52] 3 (3/0) [100/0] 18 (9/9) [50/50]
Abbreviations: GV – germinal vesicle, MI(II) - metaphase I(II), A/TI – anaphase/telophase I, GV category involves both SN (surrounded nucleolus, approximately 60%) 
and NSN (non-surrounded nucleolus) oocytes. As no differences between these two groups were detected, the data were pooled.
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from	the	young	vs.	the	older	patients.	The	first	group	contained	
fewer	oocytes	that	were	positively	labeled	with	that	antibody.	We	
did	not	find	these	differences	in	our	study.	That,	however,	may	
be	 explained	by	different	media	 that	had	been	used	 for	oocyte	
culture	before	they	were	fixed	[22].	Slightly	different	results	were	
reported	by	Huang	et	al.	[17],	who	noted	positive	labeling	for	all	
GV-staged	oocytes	(AcH4K12,	AcH3K9).	
For	AcH3K9	the	percentage	of	positively	labeled	maturing	
and	mature	oocytes	was	below	50%	in	in	vitro	matured	oocytes	
and	almost	all	in	vivo	matured	ones	were	without	labeling.	Es-
sentially,	 the	 same	situation	was	observed	when	AcH4K12	an-
tibody	was	 used.	The	 explanation	 for	 these	 differences	 is	 very	
difficult	and	one	cannot	exclude	that	certain	technical	aspects,	i.e.	
the	oocyte	culture,	handling	and	labeling,	might	have	influenced	
the	overall	pattern	of	labeling.
In	general,	 the	 interpretation	of	our	results	poses	consider-
able	challenges.	First,	it	must	be	noted	that	we	used	oocytes	from	
patients	with	 different	 fertility	 problems.	 Second,	we	 analyzed	
only	 those	oocytes	 that	did	not	 reach	 the	MII	stage	at	 the	 time	
of	their	collection	from	follicles.	The	question	remains	whether	
these	oocytes	are	somewhat	abnormal	when	compared	 to	more	
rapidly	maturing	oocytes.	It	has	been	clearly	demonstrated	that	
oocytes	maturing	 faster	are,	after	 fertilization,	developmentally	
more	 competent	 than	 those	 oocytes	 in	 which	 maturation	 lasts	
longer	 [23].	 It	 has	 been	 also	 shown	 that	 certain	manipulations	
and	culture	conditions	influence	the	level	of	methylation	(global	
DNA	methylation	and/or	histone	acetylation)	in	embryos	[20,	24,	
14].	Essentially,	 the	 labeling	 intensity	 in	manipulated	 embryos	
was	 significantly	higher	 than	 in	 controls.	Manosalva	 and	Gon-
zales	[25]	demonstrated	in	mice	that	the	consistency	of	labeling	
decreases	in	GV	stage	oocytes	with	an	increasing	female	age.	
We	hypothesize	that	there	may	be	two	possible	explanations:	
a)	human	oocytes	are	distinct	when	compared	to	other	mamma-
lian	species	tested	so	far,	b)	the	prevailing	population	of	human	
oocytes	is	abnormal.	
It	 is	 fairy	difficult	 to	determine	 these	 issues	as	human	oo-
cytes	are	primarily	used	for	test	tube	babies	production	and	spare,	
high	quality	oocytes,	are	available	only	in	exceptional	situations.
Clearly,	more	detailed	analysis	 in	 this	field	 is	necessary	 to	
account	for	the	high	frequency	of	aneuploidies	in	human	oocytes	
and	embryos,	as	well	as	to	develop	some	ways	of	their	prevention	
[26,	27].
 
Figure 1A.) Immature germinal vesicle stage human oocyte with the nucleolus 
surrounded by chromatin (arrow) labeled with anti-AcH4/K12 antibody. All oocytes 
showed the positive chromatin labeling. The same situation was observed after 
labeling with anti-hyperacetylated H4 antibody. x 400.
 
Figure 1B. Parallel DAPI staining. 
 
 
 
Figure 2A. Telophase I stage human oocyte with a weak chromosome groups 
(arrows) labeling (AcH4/K12). x 400.
 
Figure 2B. Parallel DAPI staining. 
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